{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T11:30:29Z","timestamp":1761996629376,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.clcc.2017.03.003","type":"journal-article","created":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T22:46:01Z","timestamp":1489445161000},"page":"308-315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Hepatic Arterial Infusion Chemotherapy for Unresectable Liver Metastases of Colorectal Cancer: A Multicenter Retrospective Study"],"prefix":"10.1016","volume":"16","author":[{"given":"Annie","family":"Lim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Le Sourd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne","family":"Senellart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Luet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Douane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Perret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Bouvier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"M\u00e9tairie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estelle","family":"Cauchin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Rougier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Matysiak-Budnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yann","family":"Touchefeu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clcc.2017.03.003_bib1","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clcc.2017.03.003_bib2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/annonc\/mdt591","article-title":"Metastatic pattern in colorectal cancer is strongly influenced by histological subtype","volume":"25","author":"Hugen","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clcc.2017.03.003_bib3","first-page":"496","article-title":"The clinical correlation of an autopsy study of recurrent colorectal cancer","volume":"189","author":"Welch","year":"1979","journal-title":"Ann Surg"},{"key":"10.1016\/j.clcc.2017.03.003_bib4","first-page":"1731","article-title":"Population-based audit of colorectal cancer management in two UK health regions. Colorectal Cancer Working Group, Royal College of Surgeons of England Clinical Epidemiology and Audit Unit","volume":"84","author":"Mella","year":"1997","journal-title":"Br J Surg"},{"key":"10.1016\/j.clcc.2017.03.003_bib5","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1200\/JCO.2013.53.2473","volume":"32","author":"Schwartzberg","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clcc.2017.03.003_bib6","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1200\/JCO.2008.20.5278","article-title":"Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy","volume":"27","author":"Kopetz","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clcc.2017.03.003_bib7","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/jso.24189","article-title":"Updated long-term survival for patients with metastatic colorectal cancer treated with liver resection followed by hepatic arterial infusion and systemic chemotherapy","volume":"113","author":"Kemeny","year":"2016","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.clcc.2017.03.003_bib8","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1245\/s10434-006-9068-y","article-title":"Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy","volume":"14","author":"Kornprat","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clcc.2017.03.003_bib9","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/annonc\/mdi246","article-title":"Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates","volume":"16","author":"Folprecht","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clcc.2017.03.003_bib10","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa0805019","article-title":"Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer","volume":"360","author":"Van Cutsem","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clcc.2017.03.003_bib11","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/annonc\/mdu580","article-title":"Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial","volume":"26","author":"Gruenberger","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clcc.2017.03.003_bib12","first-page":"589","article-title":"The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth","volume":"75","author":"Ackerman","year":"1974","journal-title":"Surgery"},{"key":"10.1016\/j.clcc.2017.03.003_bib13","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.jvir.2010.08.003","article-title":"Percutaneous femoral implantation of an arterial port catheter for intra-arterial chemotherapy: feasibility and predictive factors of long-term functionality","volume":"21","author":"Deschamps","year":"2010","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.clcc.2017.03.003_bib14","first-page":"176","article-title":"Clinical pharmacology of hepatic arterial chemotherapy","volume":"10","author":"Ensminger","year":"1983","journal-title":"Semin Oncol"},{"key":"10.1016\/j.clcc.2017.03.003_bib15","first-page":"3784","article-title":"A\u00a0clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2\u2032-deoxyuridine and 5-fluorouracil","volume":"38","author":"Ensminger","year":"1978","journal-title":"Cancer Res"},{"key":"10.1016\/j.clcc.2017.03.003_bib16","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/01.cad.0000131684.06390.fe","article-title":"Pharmacokinetic advantage of intra-arterial hepatic oxaliplatin administration: comparative results with cisplatin using a rabbit VX2 tumor model","volume":"15","author":"Dzodic","year":"2004","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.clcc.2017.03.003_bib17","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1200\/JCO.1992.10.7.1112","article-title":"Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial","volume":"10","author":"Rougier","year":"1992","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clcc.2017.03.003_bib18","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s11547-011-0724-3","article-title":"Hypoxic liver perfusion with mitomycin-C for treating multifocal metastases and unresectable primary tumours: a single-centre series of 42 patients","volume":"116","author":"Bagliani","year":"2011","journal-title":"Radiol Med (Torino)"},{"key":"10.1016\/j.clcc.2017.03.003_bib19","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/annonc\/mdg247","article-title":"Hepatic arterial infusion using pirarubicin combined with systemic chemotherapy: a phase II study in patients with nonresectable liver metastases from colorectal cancer","volume":"14","author":"Fallik","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clcc.2017.03.003_bib20","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1200\/JCO.2005.05.120","article-title":"Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer","volume":"23","author":"Ducreux","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clcc.2017.03.003_bib21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1245\/s10434-007-9581-7","article-title":"Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure","volume":"15","author":"Boige","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clcc.2017.03.003_bib22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/annonc\/mdv548","article-title":"Conversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIV","volume":"27","author":"L\u00e9vi","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clcc.2017.03.003_bib23","doi-asserted-by":"crossref","unstructured":"Malka D, Bourredjem A, Caramella C, Celbic A. Hepatic arterial infusion (HAI) of oxaliplatin plus intravenous (iv) fluorouracil (FU), leucovorin (LV), and cetuximab for first-line treatment of unresectable colorectal liver metastases (CRLM) (CHOICE): a multicenter phase II study. ASCO 2010 meeting.","DOI":"10.1200\/jco.2010.28.15_suppl.3558"},{"key":"10.1016\/j.clcc.2017.03.003_bib24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.suronc.2012.10.002","article-title":"Interventional revisions of malfunctions affecting surgically implanted port-catheters for hepatic artery infusion","volume":"22","author":"Farouil","year":"2013","journal-title":"Surg Oncol"},{"key":"10.1016\/j.clcc.2017.03.003_bib25","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1023\/A:1013569329846","article-title":"Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer","volume":"12","author":"Gray","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clcc.2017.03.003_bib26","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1245\/s10434-010-1288-5","article-title":"Hepatic intra-arterial injection of drug-eluting bead, irinotecan (DEBIRI) in unresectable colorectal liver metastases refractory to systemic chemotherapy: results of multi-institutional study","volume":"18","author":"Martin","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clcc.2017.03.003_bib27","first-page":"1387","article-title":"Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study","volume":"32","author":"Fiorentini","year":"2012","journal-title":"Anticancer Res"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002816302110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002816302110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:03:59Z","timestamp":1761519839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002816302110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S1533002816302110"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2017.03.003","relation":{},"ISSN":["1533-0028"],"issn-type":[{"type":"print","value":"1533-0028"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic Arterial Infusion Chemotherapy for Unresectable Liver Metastases of Colorectal Cancer: A Multicenter Retrospective Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2017.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}